Pharmaceuticals and personal care products in the environment: What are the big questions?

Autores
Boxall, Alistair B. A.; Rudd, Murray A.; Brooks, Bryan W.; Caldwell, Daniel J.; Choi, Kyungho; Hickmann, Silke; Innes, Elizabeth; Ostapyk, Kim; Staveley, Jane P.; Verslycke, Tim; Ankley, Gerald T.; Beazley, Karen F.; Belanger, Scott E.; Berninger, Jason P.; Carriquiriborde, Pedro; Coors, Anja; DeLeo, Paul C.; Dyer, Scott D.; Ericson, Jon F.; Gagné, François; Giesy, John P.; Gouin, Todd; Hallstrom, Lars; Karlsson, Maja V.; Joakim Larsson, D.G.; Lazorchak, James M.; Mastrocco, Frank; McLaughlin, Alison; McMaster, Mark E.; Meyerhoff, Roger D.; Moore, Roberta; Parrott, Joanne L.; Snape, Jason R.; Murray-Smith, Richard; Servos, Mark R.; Sibley, Paul K.; Straub, Jürg Oliver; Szabo, Nora D.; Topp, Edward; Tetreault, Gerald R.; Trudeau, Vance L.; Van Der Kraak, Glen
Año de publicación
2012
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background: Over the past 10-15 years, a substantial amount of work has been done by the scientific, regulatory, and business communities to elucidate the effects and risks of pharmaceuticals and personal care products (PPCPs) in the environment. Objective: This review was undertaken to identify key outstanding issues regarding the effects of PPCPs on human and ecological health in order to ensure that future resources will be focused on the most important areas. Data sources: To better understand and manage the risks of PPCPs in the environment, we used the "key question" approach to identify the principle issues that need to be addressed. Initially, questions were solicited from academic, government, and business communities around the world. A list of 101 questions was then discussed at an international expert workshop, and a top-20 list was developed. Following the workshop, workshop attendees ranked the 20 questions by importance. Data synthesis: The top 20 priority questions fell into seven categories: a) prioritization of substances for assessment, b) pathways of exposure, c) bioavailability and uptake, d) effects characterization, e) risk and relative risk, f) antibiotic resistance, and g) risk management. Conclusions: A large body of information is now available on PPCPs in the environment. This exercise prioritized the most critical questions to aid in development of future research programs on the topic.
Fil: Boxall, Alistair B. A.. University of York; Reino Unido
Fil: Rudd, Murray A.. University of York; Reino Unido
Fil: Brooks, Bryan W.. Baylor University; Estados Unidos
Fil: Caldwell, Daniel J.. Johnson & Johnson; Estados Unidos
Fil: Choi, Kyungho. Seoul National University; Corea del Sur
Fil: Hickmann, Silke. Umweltbundesamt; Alemania
Fil: Innes, Elizabeth. Health Canada; Canadá
Fil: Ostapyk, Kim. Health Canada; Canadá
Fil: Staveley, Jane P.. Exponent; Estados Unidos
Fil: Verslycke, Tim. Gradient; Estados Unidos
Fil: Ankley, Gerald T.. United States Environmental Protection Agency; Estados Unidos
Fil: Beazley, Karen F.. Dalhousie University Halifax; Canadá
Fil: Belanger, Scott E.. Procter And Gamble; Estados Unidos
Fil: Berninger, Jason P.. Baylor University; Estados Unidos
Fil: Carriquiriborde, Pedro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Química. Centro de Investigaciones del Medio Ambiente; Argentina
Fil: Coors, Anja. Ect Oekotoxikologie Gmbh; Alemania
Fil: DeLeo, Paul C.. American Cleaning Institute; Estados Unidos
Fil: Dyer, Scott D.. Procter And Gamble; Estados Unidos
Fil: Ericson, Jon F.. Pfizer Inc.; Estados Unidos
Fil: Gagné, François. Environment Canada; Canadá
Fil: Giesy, John P.. University of Saskatchewan; Canadá
Fil: Gouin, Todd. Unilever; Reino Unido
Fil: Hallstrom, Lars. University of Alberta; Canadá
Fil: Karlsson, Maja V.. University of York; Reino Unido
Fil: Joakim Larsson, D.G.. University of Göteborg; Alemania
Fil: Lazorchak, James M.. United States Environmental Protection Agency; Estados Unidos
Fil: Mastrocco, Frank. Pfizer Inc.; Estados Unidos
Fil: McLaughlin, Alison. Health Canada; Canadá
Fil: McMaster, Mark E.. Environment Canada; Canadá
Fil: Meyerhoff, Roger D.. Eli Lilly And Company; Estados Unidos
Fil: Moore, Roberta. Health Canada; Canadá
Fil: Parrott, Joanne L.. Environment Canada; Canadá
Fil: Snape, Jason R.. AstraZeneca UK Ltd.; Reino Unido
Fil: Murray-Smith, Richard. AstraZeneca UK Ltd.; Reino Unido
Fil: Servos, Mark R.. University of Waterloo; Canadá
Fil: Sibley, Paul K.. University of Guelph; Canadá
Fil: Straub, Jürg Oliver. F. Hoffmann-La Roche Ltd.; Suiza
Fil: Szabo, Nora D.. University of Ottawa; Canadá
Fil: Topp, Edward. Agriculture Et Agroalimentaire Canada; Canadá
Fil: Tetreault, Gerald R.. University of Waterloo; Canadá
Fil: Trudeau, Vance L.. University of Ottawa; Canadá
Fil: Van Der Kraak, Glen. University of Guelph; Canadá
Materia
ANTIBIOTIC RESISTANCE
ECOTOXICITY
EXPOSURE ASSESSMENT
HEALTH EFFECTS
PERSONAL CARE PRODUCTS
PHARMACEUTICALS
PRIORITIZATION
RISK ASSESSMENT
RISK MANAGEMENT
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/81809

id CONICETDig_15e7d002196b3e628705dbf924dc322a
oai_identifier_str oai:ri.conicet.gov.ar:11336/81809
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Pharmaceuticals and personal care products in the environment: What are the big questions?Boxall, Alistair B. A.Rudd, Murray A.Brooks, Bryan W.Caldwell, Daniel J.Choi, KyunghoHickmann, SilkeInnes, ElizabethOstapyk, KimStaveley, Jane P.Verslycke, TimAnkley, Gerald T.Beazley, Karen F.Belanger, Scott E.Berninger, Jason P.Carriquiriborde, PedroCoors, AnjaDeLeo, Paul C.Dyer, Scott D.Ericson, Jon F.Gagné, FrançoisGiesy, John P.Gouin, ToddHallstrom, LarsKarlsson, Maja V.Joakim Larsson, D.G.Lazorchak, James M.Mastrocco, FrankMcLaughlin, AlisonMcMaster, Mark E.Meyerhoff, Roger D.Moore, RobertaParrott, Joanne L.Snape, Jason R.Murray-Smith, RichardServos, Mark R.Sibley, Paul K.Straub, Jürg OliverSzabo, Nora D.Topp, EdwardTetreault, Gerald R.Trudeau, Vance L.Van Der Kraak, GlenANTIBIOTIC RESISTANCEECOTOXICITYEXPOSURE ASSESSMENTHEALTH EFFECTSPERSONAL CARE PRODUCTSPHARMACEUTICALSPRIORITIZATIONRISK ASSESSMENTRISK MANAGEMENThttps://purl.org/becyt/ford/1.5https://purl.org/becyt/ford/1Background: Over the past 10-15 years, a substantial amount of work has been done by the scientific, regulatory, and business communities to elucidate the effects and risks of pharmaceuticals and personal care products (PPCPs) in the environment. Objective: This review was undertaken to identify key outstanding issues regarding the effects of PPCPs on human and ecological health in order to ensure that future resources will be focused on the most important areas. Data sources: To better understand and manage the risks of PPCPs in the environment, we used the "key question" approach to identify the principle issues that need to be addressed. Initially, questions were solicited from academic, government, and business communities around the world. A list of 101 questions was then discussed at an international expert workshop, and a top-20 list was developed. Following the workshop, workshop attendees ranked the 20 questions by importance. Data synthesis: The top 20 priority questions fell into seven categories: a) prioritization of substances for assessment, b) pathways of exposure, c) bioavailability and uptake, d) effects characterization, e) risk and relative risk, f) antibiotic resistance, and g) risk management. Conclusions: A large body of information is now available on PPCPs in the environment. This exercise prioritized the most critical questions to aid in development of future research programs on the topic.Fil: Boxall, Alistair B. A.. University of York; Reino UnidoFil: Rudd, Murray A.. University of York; Reino UnidoFil: Brooks, Bryan W.. Baylor University; Estados UnidosFil: Caldwell, Daniel J.. Johnson & Johnson; Estados UnidosFil: Choi, Kyungho. Seoul National University; Corea del SurFil: Hickmann, Silke. Umweltbundesamt; AlemaniaFil: Innes, Elizabeth. Health Canada; CanadáFil: Ostapyk, Kim. Health Canada; CanadáFil: Staveley, Jane P.. Exponent; Estados UnidosFil: Verslycke, Tim. Gradient; Estados UnidosFil: Ankley, Gerald T.. United States Environmental Protection Agency; Estados UnidosFil: Beazley, Karen F.. Dalhousie University Halifax; CanadáFil: Belanger, Scott E.. Procter And Gamble; Estados UnidosFil: Berninger, Jason P.. Baylor University; Estados UnidosFil: Carriquiriborde, Pedro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Química. Centro de Investigaciones del Medio Ambiente; ArgentinaFil: Coors, Anja. Ect Oekotoxikologie Gmbh; AlemaniaFil: DeLeo, Paul C.. American Cleaning Institute; Estados UnidosFil: Dyer, Scott D.. Procter And Gamble; Estados UnidosFil: Ericson, Jon F.. Pfizer Inc.; Estados UnidosFil: Gagné, François. Environment Canada; CanadáFil: Giesy, John P.. University of Saskatchewan; CanadáFil: Gouin, Todd. Unilever; Reino UnidoFil: Hallstrom, Lars. University of Alberta; CanadáFil: Karlsson, Maja V.. University of York; Reino UnidoFil: Joakim Larsson, D.G.. University of Göteborg; AlemaniaFil: Lazorchak, James M.. United States Environmental Protection Agency; Estados UnidosFil: Mastrocco, Frank. Pfizer Inc.; Estados UnidosFil: McLaughlin, Alison. Health Canada; CanadáFil: McMaster, Mark E.. Environment Canada; CanadáFil: Meyerhoff, Roger D.. Eli Lilly And Company; Estados UnidosFil: Moore, Roberta. Health Canada; CanadáFil: Parrott, Joanne L.. Environment Canada; CanadáFil: Snape, Jason R.. AstraZeneca UK Ltd.; Reino UnidoFil: Murray-Smith, Richard. AstraZeneca UK Ltd.; Reino UnidoFil: Servos, Mark R.. University of Waterloo; CanadáFil: Sibley, Paul K.. University of Guelph; CanadáFil: Straub, Jürg Oliver. F. Hoffmann-La Roche Ltd.; SuizaFil: Szabo, Nora D.. University of Ottawa; CanadáFil: Topp, Edward. Agriculture Et Agroalimentaire Canada; CanadáFil: Tetreault, Gerald R.. University of Waterloo; CanadáFil: Trudeau, Vance L.. University of Ottawa; CanadáFil: Van Der Kraak, Glen. University of Guelph; CanadáU.S. Department of Health and Human Sciences. Public Health and Science2012-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/81809Boxall, Alistair B. A.; Rudd, Murray A.; Brooks, Bryan W.; Caldwell, Daniel J.; Choi, Kyungho; et al.; Pharmaceuticals and personal care products in the environment: What are the big questions?; U.S. Department of Health and Human Sciences. Public Health and Science; Environmental Health Perspectives; 120; 9; 5-2012; 1221-12291552-99240091-6765CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1289/ehp.1104477info:eu-repo/semantics/altIdentifier/url/https://ehp.niehs.nih.gov/doi/10.1289/ehp.1104477info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-29T10:23:52Zoai:ri.conicet.gov.ar:11336/81809instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-29 10:23:53.037CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Pharmaceuticals and personal care products in the environment: What are the big questions?
title Pharmaceuticals and personal care products in the environment: What are the big questions?
spellingShingle Pharmaceuticals and personal care products in the environment: What are the big questions?
Boxall, Alistair B. A.
ANTIBIOTIC RESISTANCE
ECOTOXICITY
EXPOSURE ASSESSMENT
HEALTH EFFECTS
PERSONAL CARE PRODUCTS
PHARMACEUTICALS
PRIORITIZATION
RISK ASSESSMENT
RISK MANAGEMENT
title_short Pharmaceuticals and personal care products in the environment: What are the big questions?
title_full Pharmaceuticals and personal care products in the environment: What are the big questions?
title_fullStr Pharmaceuticals and personal care products in the environment: What are the big questions?
title_full_unstemmed Pharmaceuticals and personal care products in the environment: What are the big questions?
title_sort Pharmaceuticals and personal care products in the environment: What are the big questions?
dc.creator.none.fl_str_mv Boxall, Alistair B. A.
Rudd, Murray A.
Brooks, Bryan W.
Caldwell, Daniel J.
Choi, Kyungho
Hickmann, Silke
Innes, Elizabeth
Ostapyk, Kim
Staveley, Jane P.
Verslycke, Tim
Ankley, Gerald T.
Beazley, Karen F.
Belanger, Scott E.
Berninger, Jason P.
Carriquiriborde, Pedro
Coors, Anja
DeLeo, Paul C.
Dyer, Scott D.
Ericson, Jon F.
Gagné, François
Giesy, John P.
Gouin, Todd
Hallstrom, Lars
Karlsson, Maja V.
Joakim Larsson, D.G.
Lazorchak, James M.
Mastrocco, Frank
McLaughlin, Alison
McMaster, Mark E.
Meyerhoff, Roger D.
Moore, Roberta
Parrott, Joanne L.
Snape, Jason R.
Murray-Smith, Richard
Servos, Mark R.
Sibley, Paul K.
Straub, Jürg Oliver
Szabo, Nora D.
Topp, Edward
Tetreault, Gerald R.
Trudeau, Vance L.
Van Der Kraak, Glen
author Boxall, Alistair B. A.
author_facet Boxall, Alistair B. A.
Rudd, Murray A.
Brooks, Bryan W.
Caldwell, Daniel J.
Choi, Kyungho
Hickmann, Silke
Innes, Elizabeth
Ostapyk, Kim
Staveley, Jane P.
Verslycke, Tim
Ankley, Gerald T.
Beazley, Karen F.
Belanger, Scott E.
Berninger, Jason P.
Carriquiriborde, Pedro
Coors, Anja
DeLeo, Paul C.
Dyer, Scott D.
Ericson, Jon F.
Gagné, François
Giesy, John P.
Gouin, Todd
Hallstrom, Lars
Karlsson, Maja V.
Joakim Larsson, D.G.
Lazorchak, James M.
Mastrocco, Frank
McLaughlin, Alison
McMaster, Mark E.
Meyerhoff, Roger D.
Moore, Roberta
Parrott, Joanne L.
Snape, Jason R.
Murray-Smith, Richard
Servos, Mark R.
Sibley, Paul K.
Straub, Jürg Oliver
Szabo, Nora D.
Topp, Edward
Tetreault, Gerald R.
Trudeau, Vance L.
Van Der Kraak, Glen
author_role author
author2 Rudd, Murray A.
Brooks, Bryan W.
Caldwell, Daniel J.
Choi, Kyungho
Hickmann, Silke
Innes, Elizabeth
Ostapyk, Kim
Staveley, Jane P.
Verslycke, Tim
Ankley, Gerald T.
Beazley, Karen F.
Belanger, Scott E.
Berninger, Jason P.
Carriquiriborde, Pedro
Coors, Anja
DeLeo, Paul C.
Dyer, Scott D.
Ericson, Jon F.
Gagné, François
Giesy, John P.
Gouin, Todd
Hallstrom, Lars
Karlsson, Maja V.
Joakim Larsson, D.G.
Lazorchak, James M.
Mastrocco, Frank
McLaughlin, Alison
McMaster, Mark E.
Meyerhoff, Roger D.
Moore, Roberta
Parrott, Joanne L.
Snape, Jason R.
Murray-Smith, Richard
Servos, Mark R.
Sibley, Paul K.
Straub, Jürg Oliver
Szabo, Nora D.
Topp, Edward
Tetreault, Gerald R.
Trudeau, Vance L.
Van Der Kraak, Glen
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ANTIBIOTIC RESISTANCE
ECOTOXICITY
EXPOSURE ASSESSMENT
HEALTH EFFECTS
PERSONAL CARE PRODUCTS
PHARMACEUTICALS
PRIORITIZATION
RISK ASSESSMENT
RISK MANAGEMENT
topic ANTIBIOTIC RESISTANCE
ECOTOXICITY
EXPOSURE ASSESSMENT
HEALTH EFFECTS
PERSONAL CARE PRODUCTS
PHARMACEUTICALS
PRIORITIZATION
RISK ASSESSMENT
RISK MANAGEMENT
purl_subject.fl_str_mv https://purl.org/becyt/ford/1.5
https://purl.org/becyt/ford/1
dc.description.none.fl_txt_mv Background: Over the past 10-15 years, a substantial amount of work has been done by the scientific, regulatory, and business communities to elucidate the effects and risks of pharmaceuticals and personal care products (PPCPs) in the environment. Objective: This review was undertaken to identify key outstanding issues regarding the effects of PPCPs on human and ecological health in order to ensure that future resources will be focused on the most important areas. Data sources: To better understand and manage the risks of PPCPs in the environment, we used the "key question" approach to identify the principle issues that need to be addressed. Initially, questions were solicited from academic, government, and business communities around the world. A list of 101 questions was then discussed at an international expert workshop, and a top-20 list was developed. Following the workshop, workshop attendees ranked the 20 questions by importance. Data synthesis: The top 20 priority questions fell into seven categories: a) prioritization of substances for assessment, b) pathways of exposure, c) bioavailability and uptake, d) effects characterization, e) risk and relative risk, f) antibiotic resistance, and g) risk management. Conclusions: A large body of information is now available on PPCPs in the environment. This exercise prioritized the most critical questions to aid in development of future research programs on the topic.
Fil: Boxall, Alistair B. A.. University of York; Reino Unido
Fil: Rudd, Murray A.. University of York; Reino Unido
Fil: Brooks, Bryan W.. Baylor University; Estados Unidos
Fil: Caldwell, Daniel J.. Johnson & Johnson; Estados Unidos
Fil: Choi, Kyungho. Seoul National University; Corea del Sur
Fil: Hickmann, Silke. Umweltbundesamt; Alemania
Fil: Innes, Elizabeth. Health Canada; Canadá
Fil: Ostapyk, Kim. Health Canada; Canadá
Fil: Staveley, Jane P.. Exponent; Estados Unidos
Fil: Verslycke, Tim. Gradient; Estados Unidos
Fil: Ankley, Gerald T.. United States Environmental Protection Agency; Estados Unidos
Fil: Beazley, Karen F.. Dalhousie University Halifax; Canadá
Fil: Belanger, Scott E.. Procter And Gamble; Estados Unidos
Fil: Berninger, Jason P.. Baylor University; Estados Unidos
Fil: Carriquiriborde, Pedro. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina. Universidad Nacional de La Plata. Facultad de Ciencias Exactas. Departamento de Química. Centro de Investigaciones del Medio Ambiente; Argentina
Fil: Coors, Anja. Ect Oekotoxikologie Gmbh; Alemania
Fil: DeLeo, Paul C.. American Cleaning Institute; Estados Unidos
Fil: Dyer, Scott D.. Procter And Gamble; Estados Unidos
Fil: Ericson, Jon F.. Pfizer Inc.; Estados Unidos
Fil: Gagné, François. Environment Canada; Canadá
Fil: Giesy, John P.. University of Saskatchewan; Canadá
Fil: Gouin, Todd. Unilever; Reino Unido
Fil: Hallstrom, Lars. University of Alberta; Canadá
Fil: Karlsson, Maja V.. University of York; Reino Unido
Fil: Joakim Larsson, D.G.. University of Göteborg; Alemania
Fil: Lazorchak, James M.. United States Environmental Protection Agency; Estados Unidos
Fil: Mastrocco, Frank. Pfizer Inc.; Estados Unidos
Fil: McLaughlin, Alison. Health Canada; Canadá
Fil: McMaster, Mark E.. Environment Canada; Canadá
Fil: Meyerhoff, Roger D.. Eli Lilly And Company; Estados Unidos
Fil: Moore, Roberta. Health Canada; Canadá
Fil: Parrott, Joanne L.. Environment Canada; Canadá
Fil: Snape, Jason R.. AstraZeneca UK Ltd.; Reino Unido
Fil: Murray-Smith, Richard. AstraZeneca UK Ltd.; Reino Unido
Fil: Servos, Mark R.. University of Waterloo; Canadá
Fil: Sibley, Paul K.. University of Guelph; Canadá
Fil: Straub, Jürg Oliver. F. Hoffmann-La Roche Ltd.; Suiza
Fil: Szabo, Nora D.. University of Ottawa; Canadá
Fil: Topp, Edward. Agriculture Et Agroalimentaire Canada; Canadá
Fil: Tetreault, Gerald R.. University of Waterloo; Canadá
Fil: Trudeau, Vance L.. University of Ottawa; Canadá
Fil: Van Der Kraak, Glen. University of Guelph; Canadá
description Background: Over the past 10-15 years, a substantial amount of work has been done by the scientific, regulatory, and business communities to elucidate the effects and risks of pharmaceuticals and personal care products (PPCPs) in the environment. Objective: This review was undertaken to identify key outstanding issues regarding the effects of PPCPs on human and ecological health in order to ensure that future resources will be focused on the most important areas. Data sources: To better understand and manage the risks of PPCPs in the environment, we used the "key question" approach to identify the principle issues that need to be addressed. Initially, questions were solicited from academic, government, and business communities around the world. A list of 101 questions was then discussed at an international expert workshop, and a top-20 list was developed. Following the workshop, workshop attendees ranked the 20 questions by importance. Data synthesis: The top 20 priority questions fell into seven categories: a) prioritization of substances for assessment, b) pathways of exposure, c) bioavailability and uptake, d) effects characterization, e) risk and relative risk, f) antibiotic resistance, and g) risk management. Conclusions: A large body of information is now available on PPCPs in the environment. This exercise prioritized the most critical questions to aid in development of future research programs on the topic.
publishDate 2012
dc.date.none.fl_str_mv 2012-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/81809
Boxall, Alistair B. A.; Rudd, Murray A.; Brooks, Bryan W.; Caldwell, Daniel J.; Choi, Kyungho; et al.; Pharmaceuticals and personal care products in the environment: What are the big questions?; U.S. Department of Health and Human Sciences. Public Health and Science; Environmental Health Perspectives; 120; 9; 5-2012; 1221-1229
1552-9924
0091-6765
CONICET Digital
CONICET
url http://hdl.handle.net/11336/81809
identifier_str_mv Boxall, Alistair B. A.; Rudd, Murray A.; Brooks, Bryan W.; Caldwell, Daniel J.; Choi, Kyungho; et al.; Pharmaceuticals and personal care products in the environment: What are the big questions?; U.S. Department of Health and Human Sciences. Public Health and Science; Environmental Health Perspectives; 120; 9; 5-2012; 1221-1229
1552-9924
0091-6765
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1289/ehp.1104477
info:eu-repo/semantics/altIdentifier/url/https://ehp.niehs.nih.gov/doi/10.1289/ehp.1104477
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv U.S. Department of Health and Human Sciences. Public Health and Science
publisher.none.fl_str_mv U.S. Department of Health and Human Sciences. Public Health and Science
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1844614234947715072
score 13.070432